Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.77
+0.73 (2.70%)
At close: Jul 31, 2026, 4:00 PM EDT
27.60
-0.17 (-0.61%)
After-hours: Jul 31, 2026, 7:58 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $608.10M in the quarter ending March 31, 2026, with 3.77% growth. This brings the company's revenue in the last twelve months to $2.37B, up 32.81% year-over-year. In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth.
Revenue (ttm)
$2.37B
Revenue Growth
+32.81%
P/S Ratio
2.71
Revenue / Employee
$970,406
Employees
2,442
Market Cap
6.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.12M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.89B |
| Dr. Reddy's Laboratories | 3.50B |
| Amneal Pharmaceuticals | 3.12B |
| Alkermes | 1.67B |
| Lantheus Holdings | 1.55B |
| Indivior Pharmaceuticals | 1.29B |
| BioCryst Pharmaceuticals | 885.72M |
| Kiniksa Pharmaceuticals International, | 840.85M |
HIMS News
- 1 day ago - HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law - Business Wire
- 1 day ago - Hims & Hers Stock Jumps on Vow to ‘Vigorously’ Defend Against FTC’s ‘Baseless Claims’ - TipRanks
- 1 day ago - FTC sues Hims & Hers for allegedly sharing patients' medical data with advertisers Meta and Snap - TechCrunch
- 2 days ago - Hims & Hers sent users' health data to social media giants despite promising privacy, bombshell FTC lawsuit claims - New York Post
- 2 days ago - Hims and Hers shares fall 10% as FTC sues company over data, billing practices - CNBC
- 2 days ago - FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech - Forbes
- 2 days ago - Hims & Hers Responds to FTC Lawsuit - Business Wire
- 2 days ago - Hims & Hers Health Stock Sinks on Privacy, Deceptive Billing Lawsuit - TipRanks